Infectious
diseases are caused by organisms such as bacteria, viruses, fungi,
and parasites and are capable of transmission from one species to
another species. Diagnosis of these diseases involves identifying the
pathogen and its type and the degree up to which the infection has
spread. Infectious diseases such as HIV, tuberculosis, malaria, and
Influenza are highly prevalent and can be efficiently diagnosed with
the help of diagnostic tests available for the respective diseases.
Technologies
utilized by these diagnostic tests are classified into biochemical
techniques, molecular techniques, immunodiagnostics, and conventional
culturing, and staining techniques. Biochemical techniques include
ELISA, agglutination, and others, while molecular techniques include
Polymerase Chain Reaction (PCR) and Next-Generation Sequencing
techniques. These tests are capable of diagnosing the infectious
diseases accurately with high throughput capacity.
Request
Sample of Report:
https://www.coherentmarketinsights.com/insight/request-sample/1971
Increasing
prevalence of various infectious diseases is expected to boost the
infectious disease diagnostics market growth over the forecast period
Infectious
diseases such as HIV, tuberculosis, and malaria are prevalent in
emerging economies such as Africa and Asia Pacific. For instance,
according to the World Health Organization (WHO), an estimated 36.7
million people were suffering from HIV in 2016.
According
to the World Health Organization (WHO), in 2015, an estimated 32,000
deaths from tuberculosis and around 323,000 new cases of TB cases
were registered in the Europe. Moreover, around 323,000 incident of
TB cases in this region includes 27,000 cases with HIV co-infection.
The
global infectious disease diagnostics market size was valued at US$
15,112.2 million in 2017, and is expected to witness a robust CAGR of
6.1% over the forecast period (2018 – 2026).
Partnerships
and collaborations by market players to develop novel diagnostic
techniques is expected to boost growth of the infectious disease
diagnostics market
Individual
organizations, manufacturers, and research institutes are forming
partnerships, and collaborations to advance research and development
of diagnostic tests for infectious diseases. Moreover, funding by
individual organizations to advance research is expected to boost the
growth of the market over the forecast period. For instance, the
University of Virginia’s Global Infectious Diseases Institute
funded seven projects designed to tackle challenging problems in
infectious diseases worldwide in July 2018. They have formed
collaborative teams across diverse academic disciplines to control
and treat Zika virus infections and to reduce tuberculosis rates
among HIV-infected patients in Africa.
Key
Players
Some
of the major players operating in the global infectious disease
diagnostics market include Danaher Corporation, Abbott Laboratories,
Becton, Dickinson, and Company, F.Hoffmann La-Roche Ltd., Trinity
Biotech Plc., Cardinal Health, Inc., BioMérieux, Bio-Rad
Laboratories, Inc., AccuBioTech, Co. Ltd., and Acon Laboratories,
Inc.
Detailed
Segmentation:
Global
Infectious Disease Diagnostics Market, By Disease Type:
-
HIV
-
Hepatitis
-
Healthcare Associated Infections (HAIs)
-
Human Papillomavirus (HPV)
-
Tuberculosis (TB)
-
Influenza
-
Others
Global
Infectious Disease Diagnostics Market, By Technology:
-
Immunodiagnostics
-
Polymerase Chain Reaction (PCR)
-
Next Generation Sequencing (NGS)
-
Others
Browse
Full Report:
https://www.coherentmarketinsights.com/market-insight/infectious-disease-diagnostics-market-1971
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment